Flunisolide (marketed as AeroBid, Nasalide, Nasarel) is a corticosteroid with anti-inflammatory actions. It is often prescribed as treatment for allergic rhinitis and its principle mechanism of action involves activation of glucocorticoid receptors.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Denosumab | The risk or severity of adverse effects can be increased when Denosumab is combined with Flunisolide. |
| Peginterferon alfa-2a | The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Flunisolide. |
| Interferon alfa-n1 | The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Flunisolide. |
| Interferon alfa-n3 | The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flunisolide. |
| Peginterferon alfa-2b | The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flunisolide. |
| Interferon gamma-1b | The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flunisolide. |
| Interferon alfa-2a | The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Flunisolide. |
| Aldesleukin | The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flunisolide. |
| Gemtuzumab ozogamicin | The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Flunisolide. |
| Pegaspargase | The risk or severity of adverse effects can be increased when Pegaspargase is combined with Flunisolide. |
| Interferon beta-1b | The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Flunisolide. |
| Interferon alfacon-1 | The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Flunisolide. |
| Rituximab | The risk or severity of adverse effects can be increased when Rituximab is combined with Flunisolide. |
| Basiliximab | The risk or severity of adverse effects can be increased when Basiliximab is combined with Flunisolide. |
| Muromonab | The risk or severity of adverse effects can be increased when Muromonab is combined with Flunisolide. |
| Ibritumomab tiuxetan | The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Flunisolide. |
| Tositumomab | The risk or severity of adverse effects can be increased when Tositumomab is combined with Flunisolide. |
| Alemtuzumab | The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Flunisolide. |
| Alefacept | The risk or severity of adverse effects can be increased when Alefacept is combined with Flunisolide. |
| Efalizumab | The risk or severity of adverse effects can be increased when Efalizumab is combined with Flunisolide. |
| Antithymocyte immunoglobulin (rabbit) | The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Flunisolide. |
| Interferon alfa-2b | The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Flunisolide. |
| Daclizumab | The risk or severity of adverse effects can be increased when Daclizumab is combined with Flunisolide. |
| Phenylalanine | The risk or severity of adverse effects can be increased when Phenylalanine is combined with Flunisolide. |
| Cladribine | Flunisolide may increase the immunosuppressive activities of Cladribine. |
| Carmustine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Carmustine. |
| Amsacrine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Amsacrine. |
| Bleomycin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Bleomycin. |
| Chlorambucil | The risk or severity of adverse effects can be increased when Flunisolide is combined with Chlorambucil. |
| Raltitrexed | The risk or severity of adverse effects can be increased when Flunisolide is combined with Raltitrexed. |
| Mitomycin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Mitomycin. |
| Bexarotene | The risk or severity of adverse effects can be increased when Flunisolide is combined with Bexarotene. |
| Floxuridine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Floxuridine. |
| Tioguanine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Tioguanine. |
| Dexrazoxane | The risk or severity of adverse effects can be increased when Flunisolide is combined with Dexrazoxane. |
| Streptozocin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Streptozocin. |
| Trifluridine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Trifluridine. |
| Gemcitabine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Gemcitabine. |
| Epirubicin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Epirubicin. |
| Chloramphenicol | The risk or severity of adverse effects can be increased when Flunisolide is combined with Chloramphenicol. |
| Lenalidomide | The risk or severity of adverse effects can be increased when Flunisolide is combined with Lenalidomide. |
| Altretamine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Altretamine. |
| Zidovudine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Zidovudine. |
| Oxaliplatin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Oxaliplatin. |
| Fluorouracil | The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluorouracil. |
| Propylthiouracil | The risk or severity of adverse effects can be increased when Flunisolide is combined with Propylthiouracil. |
| Pentostatin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Pentostatin. |
| Linezolid | The risk or severity of adverse effects can be increased when Flunisolide is combined with Linezolid. |
| Clofarabine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Clofarabine. |
| Pemetrexed | The risk or severity of adverse effects can be increased when Flunisolide is combined with Pemetrexed. |
| Mycophenolate mofetil | The risk or severity of adverse effects can be increased when Flunisolide is combined with Mycophenolate mofetil. |
| Dacarbazine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Dacarbazine. |
| Temozolomide | The risk or severity of adverse effects can be increased when Flunisolide is combined with Temozolomide. |
| Penicillamine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Penicillamine. |
| Azacitidine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Azacitidine. |
| Carboplatin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Carboplatin. |
| Dactinomycin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Dactinomycin. |
| Azathioprine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Azathioprine. |
| Hydroxyurea | The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydroxyurea. |
| Mycophenolic acid | The risk or severity of adverse effects can be increased when Flunisolide is combined with Mycophenolic acid. |
| Topotecan | The risk or severity of adverse effects can be increased when Flunisolide is combined with Topotecan. |
| Mercaptopurine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Mercaptopurine. |
| Thalidomide | The risk or severity of adverse effects can be increased when Flunisolide is combined with Thalidomide. |
| Melphalan | The risk or severity of adverse effects can be increased when Flunisolide is combined with Melphalan. |
| Fludarabine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Fludarabine. |
| Flucytosine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Flucytosine. |
| Capecitabine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Capecitabine. |
| Procarbazine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Procarbazine. |
| Arsenic trioxide | The risk or severity of adverse effects can be increased when Flunisolide is combined with Arsenic trioxide. |
| Idarubicin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Idarubicin. |
| Estramustine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Estramustine. |
| Mitoxantrone | The risk or severity of adverse effects can be increased when Flunisolide is combined with Mitoxantrone. |
| Lomustine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Lomustine. |
| Eculizumab | The risk or severity of adverse effects can be increased when Flunisolide is combined with Eculizumab. |
| Decitabine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Decitabine. |
| Nelarabine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Nelarabine. |
| Stepronin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Stepronin. |
| Hydroxychloroquine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Hydroxychloroquine. |
| Castanospermine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Castanospermine. |
| Vorinostat | The risk or severity of adverse effects can be increased when Flunisolide is combined with Vorinostat. |
| 2-Methoxyethanol | The risk or severity of adverse effects can be increased when Flunisolide is combined with 2-Methoxyethanol. |
| Brequinar | The risk or severity of adverse effects can be increased when Flunisolide is combined with Brequinar. |
| Pirfenidone | The risk or severity of adverse effects can be increased when Flunisolide is combined with Pirfenidone. |
| Interferon alfa | The risk or severity of adverse effects can be increased when Flunisolide is combined with Interferon alfa. |
| Glatiramer | The risk or severity of adverse effects can be increased when Flunisolide is combined with Glatiramer. |
| Briakinumab | The risk or severity of adverse effects can be increased when Flunisolide is combined with Briakinumab. |
| Human interferon omega-1 | The risk or severity of adverse effects can be increased when Flunisolide is combined with Human interferon omega-1. |
| Mepolizumab | The risk or severity of adverse effects can be increased when Flunisolide is combined with Mepolizumab. |
| Abetimus | The risk or severity of adverse effects can be increased when Flunisolide is combined with Abetimus. |
| Belatacept | The risk or severity of adverse effects can be increased when Flunisolide is combined with Belatacept. |
| Bendamustine | The risk or severity of adverse effects can be increased when Flunisolide is combined with Bendamustine. |
| Pralatrexate | The risk or severity of adverse effects can be increased when Flunisolide is combined with Pralatrexate. |
| Wortmannin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Wortmannin. |
| Eribulin | The risk or severity of adverse effects can be increased when Flunisolide is combined with Eribulin. |
| Belimumab | The risk or severity of adverse effects can be increased when Flunisolide is combined with Belimumab. |
| Teriflunomide | The risk or severity of adverse effects can be increased when Flunisolide is combined with Teriflunomide. |
| Carfilzomib | The risk or severity of adverse effects can be increased when Flunisolide is combined with Carfilzomib. |
| Dimethyl fumarate | The risk or severity of adverse effects can be increased when Flunisolide is combined with Dimethyl fumarate. |
| Obinutuzumab | The risk or severity of adverse effects can be increased when Flunisolide is combined with Obinutuzumab. |
| Vedolizumab | The risk or severity of adverse effects can be increased when Flunisolide is combined with Vedolizumab. |